Company Filing History:
Years Active: 2002
Title: Eriko Morita: Innovator in Serotonin Receptor Compounds
Introduction
Eriko Morita is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that interact with serotonin receptors. His work is crucial for advancing treatments for various mental health conditions.
Latest Patents
Morita holds 2 patents that focus on innovative compounds. His latest patents include the following:
1. **Tetrahydrobenzindole derivatives** - These compounds contain tetrahydrobenzindole, which binds to serotonin receptors and is useful in the treatment or prevention of diseases induced by abnormalities in central and peripheral serotonin controlling functions.
2. **Optically active tetrahydrobenzindole derivative** - This patent describes optically active tetrahydrobenzindole type compounds that have an affinity for a 5-HT receptor, making them useful for the prevention and treatment of mental diseases. A specific compound mentioned is (S)-2a-4-(4-(2-methoxyphenyl)piperazinyl)butyl)-2a,3,4,5,-tetrahydro 1 H-benz[cd]indol-2-one.
Career Highlights
Eriko Morita is currently employed at Meiji Seika Kaisha, Ltd., where he continues to innovate in the field of pharmaceutical compounds. His work has garnered attention for its potential impact on mental health treatments.
Collaborations
Morita collaborates with talented coworkers, including Chika Kikuchi and Takashi Ando. Their combined expertise contributes to the advancement of their research and development efforts.
Conclusion
Eriko Morita's contributions to the field of serotonin receptor compounds highlight his role as an influential inventor. His patents reflect a commitment to improving mental health treatments through innovative chemistry.